secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRAIL, Inc. (GRAL)
CIK:        0001699031
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001628280-26-030495
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRAIL Q1 2026: revenue $40.8M (up 28%), Galleri volume 56k+ (up 50%), net loss $93.2M
--------------------------------------------------------------------------------

- Total revenue $40.8M (+28% YoY); Galleri revenue $39.8M (+37%); test volume >56,000 (+50%).
- Net loss $93.2M, improved $13.0M (12%) vs Q1 2025; adjusted EBITDA $(79.9)M, improved 19%.
- Adjusted gross profit $19.7M (+38% YoY); cash & equivalents $823.1M.
- Plans to integrate Galleri into Epic EHR; new NHS-Galleri and PATHFINDER 2 data at ASCO 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699031/000162828026030495/0001628280-26-030495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699031/000162828026030495/gral-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-030495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer